Commentary
Commentary
The Big Beautiful Bill Fixes One Drug Problem—But Highlights An Even Bigger One
Buried within the One Big Beautiful Bill Act, which President Donald Trump signed into law July 4, is a provision that could improve or even save the lives of the 30 million Americans suffering from rare diseases. That provision is the Orphan Cures Act, which exempts certain drugs that treat ...
Commentary
Now what, California?
President Donald Trump’s Big Beautiful Bill is a grotesque monster to the renewable energy partisans. It phases out subsidies for wind and solar power, which have been around for decades and were extended by the previous administration’s Inflation Reduction Act. Industry sources have told the media that without taxpayer help, ...
Commentary
One Big Beautiful Bill: A Fiscal Lifeline for Medicaid, Taxpayers
The “One Big Beautiful Bill” Act (OBBBA) signed into law by President Donald Trump on July 4 is set to help pull America’s healthcare system back from the brink of fiscal disaster. Read the entire op-ed here.
Commentary
The Culprit Impeding Drug Competition Is Not Who The Feds Expected
The Federal Trade Commission and U.S. Department of Justice recently kicked off a series of listening sessions to examine barriers to competition in the drug industry. The title of the first session—”Anticompetitive Conduct by Pharmaceutical Companies”—made it seem that regulators would chiefly investigate biotech firms. Yet by the end, panelists ...
Commentary
No, Donald Trump didn’t just slash Medicaid
Republicans’ One Big Beautiful Bill Act is now law. Democrats have wasted no time accusing the GOP of enshrining devastating “cuts” to Medicaid, the joint federal-state entitlement that provides health coverage for low-income Americans. That’s rubbish. The measure takes steps to restrain Medicaid’s rampant growth in recent years so that ...
Commentary
Cheap Drugs from Canada Can’t Make America Healthy
The U.S. Food and Drug Administration just announced plans to help states and Indian tribes purchase certain prescription drugs from Canada, where brand-name medicines tend to be cheaper because the government caps their price. The new guidance is part of a larger Trump administration effort to cut drug prices for ...
Commentary
As PBMs Drive Up Drug Prices, Silence Is Not Golden
The Trump administration has been mum in recent weeks on its “most favored nation” drug pricing plan, which broadly aims to link U.S. prices for medicines to the lowest prices in other developed countries. It’s unclear what those prices will be, how they’ll be determined, or how the administration will ...
Commentary
California Shouldn’t Set America’s Environmental Policy
For decades, California has made environmental policy as if it were a sovereign nation, not an equal member of the Union. The federal government granted it this privilege on the premise that the Golden State faced uniquely urgent challenges requiring special treatment. Over time, that sense of exceptionalism has only ...
California
The California Left Coast Survivor’s Guide on C-SPAN’s Book TV
This C-Span interview was conducted at FreedomFest, an annual libertarian conference held in 2025 in Palm Springs, California.
Commentary
A Promising New AIDS Drug Highlights The Dangers Of Price Controls
The U.S. Food and Drug Administration approved a shot last month that effectively prevents HIV. At-risk people simply need to receive the injection every six months. The new drug, called lenacapavir, comes almost exactly 44 years after the first case of AIDS was reported by what’s now known as the ...
The Big Beautiful Bill Fixes One Drug Problem—But Highlights An Even Bigger One
Buried within the One Big Beautiful Bill Act, which President Donald Trump signed into law July 4, is a provision that could improve or even save the lives of the 30 million Americans suffering from rare diseases. That provision is the Orphan Cures Act, which exempts certain drugs that treat ...
Now what, California?
President Donald Trump’s Big Beautiful Bill is a grotesque monster to the renewable energy partisans. It phases out subsidies for wind and solar power, which have been around for decades and were extended by the previous administration’s Inflation Reduction Act. Industry sources have told the media that without taxpayer help, ...
One Big Beautiful Bill: A Fiscal Lifeline for Medicaid, Taxpayers
The “One Big Beautiful Bill” Act (OBBBA) signed into law by President Donald Trump on July 4 is set to help pull America’s healthcare system back from the brink of fiscal disaster. Read the entire op-ed here.
The Culprit Impeding Drug Competition Is Not Who The Feds Expected
The Federal Trade Commission and U.S. Department of Justice recently kicked off a series of listening sessions to examine barriers to competition in the drug industry. The title of the first session—”Anticompetitive Conduct by Pharmaceutical Companies”—made it seem that regulators would chiefly investigate biotech firms. Yet by the end, panelists ...
No, Donald Trump didn’t just slash Medicaid
Republicans’ One Big Beautiful Bill Act is now law. Democrats have wasted no time accusing the GOP of enshrining devastating “cuts” to Medicaid, the joint federal-state entitlement that provides health coverage for low-income Americans. That’s rubbish. The measure takes steps to restrain Medicaid’s rampant growth in recent years so that ...
Cheap Drugs from Canada Can’t Make America Healthy
The U.S. Food and Drug Administration just announced plans to help states and Indian tribes purchase certain prescription drugs from Canada, where brand-name medicines tend to be cheaper because the government caps their price. The new guidance is part of a larger Trump administration effort to cut drug prices for ...
As PBMs Drive Up Drug Prices, Silence Is Not Golden
The Trump administration has been mum in recent weeks on its “most favored nation” drug pricing plan, which broadly aims to link U.S. prices for medicines to the lowest prices in other developed countries. It’s unclear what those prices will be, how they’ll be determined, or how the administration will ...
California Shouldn’t Set America’s Environmental Policy
For decades, California has made environmental policy as if it were a sovereign nation, not an equal member of the Union. The federal government granted it this privilege on the premise that the Golden State faced uniquely urgent challenges requiring special treatment. Over time, that sense of exceptionalism has only ...
The California Left Coast Survivor’s Guide on C-SPAN’s Book TV
This C-Span interview was conducted at FreedomFest, an annual libertarian conference held in 2025 in Palm Springs, California.
A Promising New AIDS Drug Highlights The Dangers Of Price Controls
The U.S. Food and Drug Administration approved a shot last month that effectively prevents HIV. At-risk people simply need to receive the injection every six months. The new drug, called lenacapavir, comes almost exactly 44 years after the first case of AIDS was reported by what’s now known as the ...
